{"id":5827,"date":"2020-06-26T11:18:42","date_gmt":"2020-06-26T09:18:42","guid":{"rendered":"http:\/\/www.seventure.fr\/wp-content\/uploads\/2020\/06\/20-ENTEROME-02-Financing-DRAFT-CP-EN-vFinal.pdf"},"modified":"2020-06-26T11:18:42","modified_gmt":"2020-06-26T09:18:42","slug":"20-enterome-02-financing-draft-cp-en-vfinal","status":"inherit","type":"attachment","link":"https:\/\/www.seventure.fr\/en\/enterome-completes-e46-3-million-52-6-million-financing-to-progress-the-clinical-development-of-its-therapeutic-pipeline\/20-enterome-02-financing-draft-cp-en-vfinal\/","title":{"rendered":"20-ENTEROME-02-Financing-DRAFT-CP-EN-vFinal"},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false},"class_list":["post-5827","attachment","type-attachment","status-inherit","hentry"],"acf":[],"yoast_head":"\n